Rob Dillard

DocwireNews

A new study found that, worldwide, aspirin is underused as a prevention measure in individuals with a history of cardiovascular disease (CVD). The findings were <a href="https://jamanetwork.com/journals/jama/article-abstract/2808523">reported</a> in JAMA.&ldquo;Aspirin is an effective and low-cost option for reducing CVD events and improving mortality rates among individuals with established CVD. To guide efforts to mitigate the global CVD burden, there is a need to understand current levels of aspirin use for secondary prevention of CVD,&rdquo; the researchers wrote.In this&nbsp;cross-sectional analysis, researchers assessed pooled individual participant data from national health surveys conducted between 2013 and 2020 in 51 low-, middle-, and high-income countries. The overall sample consisted of 124,505 individuals aged 40 to 69 years who self-reported their history of CVD and aspirin use.<h2>Use Rate Is Poor in Low-Income Countries</h2>The findings showed that among individuals with a history of CVD, aspirin use for secondary prevention in the overall pooled sample was less than half (40.3%). A total of 16.6% (95% CI, 12.4-21.9) of individuals with a history of CVD in low-income countries, 24.5% (95% CI, 20.8-28.6) in lower-middle-income countries, 51.1% (95% CI, 48.2-54.0) in upper-middle-income countries, and 65.0% (95% CI, 59.1-70.4) in high-income countries used aspirin for the purpose of secondary prevention.&ldquo;Worldwide, aspirin is underused in secondary prevention, particularly in low-income countries. National health policies and health systems must develop, implement, and evaluate strategies to promote aspirin therapy,&rdquo; the researchers concluded.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Individuals With a History of Heart Disease Are Underusing Aspirin

Preventive Cardiology

A new study found that, worldwide, aspirin is underused as a prevention measure in individuals with a history of CVD.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe